166 related articles for article (PubMed ID: 34513837)
1. Stimulation of Treg Cells to Inhibit Osteoclastogenesis in Gorham-Stout Disease.
Rossi M; Rana I; Buonuomo PS; Battafarano G; De Martino V; D'Agostini M; Porzio O; Cipriani C; Minisola S; De Vito R; Vecchio D; Gonfiantini MV; Jenkner A; Bartuli A; Del Fattore A
Front Cell Dev Biol; 2021; 9():706596. PubMed ID: 34513837
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the mechanisms of bone loss in Gorham-Stout disease.
Rossi M; Buonuomo PS; Battafarano G; Conforti A; Mariani E; Algeri M; Pelle S; D'Agostini M; Macchiaiolo M; De Vito R; Gonfiantini MV; Jenkner A; Rana I; Bartuli A; Del Fattore A
Bone; 2020 Jan; 130():115068. PubMed ID: 31525474
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated miRNAs in bone cells of patients with Gorham-Stout disease.
Rossi M; Rana I; Buonuomo PS; Battafarano G; Mariani E; D'Agostini M; Porzio O; De Martino V; Minisola S; Macchiaiolo M; De Vito R; Vecchio D; Gonfiantini MV; Jenkner A; Bartuli A; Del Fattore A
FASEB J; 2021 Mar; 35(3):e21424. PubMed ID: 33609323
[TBL] [Abstract][Full Text] [Related]
4. Viewpoints on vessels and vanishing bones in Gorham-Stout disease.
Dellinger MT; Garg N; Olsen BR
Bone; 2014 Jun; 63():47-52. PubMed ID: 24583233
[TBL] [Abstract][Full Text] [Related]
5. Analysis of circulating osteoclast and osteogenic precursors in patients with Gorham-Stout disease.
Rossi M; Terreri S; Battafarano G; Rana I; Buonuomo PS; Di Giuseppe L; D'Agostini M; Porzio O; Di Gregorio J; Cipriani C; Jenkner A; Gonfiantini MV; Bartuli A; Del Fattore A
J Endocrinol Invest; 2024 Apr; ():. PubMed ID: 38556572
[TBL] [Abstract][Full Text] [Related]
6. Craniofacial CT findings of Gorham-Stout disease and generalized lymphatic anomaly.
Kato H; Ozeki M; Fukao T; Matsuo M
Neuroradiology; 2016 Aug; 58(8):801-6. PubMed ID: 27126342
[TBL] [Abstract][Full Text] [Related]
7. Gorham-Stout disease with parietal bone osteolysis: a case series and review of literature.
Takaya K; Sakamoto Y; Miwa T; Yoshida K; Kishi K
Br J Neurosurg; 2021 Feb; 35(1):27-31. PubMed ID: 32216589
[TBL] [Abstract][Full Text] [Related]
8. Gorham-Stout disease successfully treated with sirolimus (rapamycin): a case report and review of the literature.
Liang Y; Tian R; Wang J; Shan Y; Gao H; Xie C; Li J; Xu M; Gu S
BMC Musculoskelet Disord; 2020 Aug; 21(1):577. PubMed ID: 32843029
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease.
Devlin RD; Bone HG; Roodman GD
J Clin Endocrinol Metab; 1996 May; 81(5):1893-7. PubMed ID: 8626854
[TBL] [Abstract][Full Text] [Related]
10. Gorham-Stout Disease: a Clinical Case Report and Immunological Mechanisms in Bone Erosion.
Franco-Barrera MJ; Zavala-Cerna MG; Aguilar-Portillo G; Sánchez-Gomez DB; Torres-Bugarin O; Franco-Barrera MA; Roa-Encarnacion CM
Clin Rev Allergy Immunol; 2017 Feb; 52(1):125-132. PubMed ID: 28004375
[TBL] [Abstract][Full Text] [Related]
11. Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease.
Colucci S; Taraboletti G; Primo L; Viale A; Roca C; Valdembri D; Geuna M; Pagano M; Grano M; Pogrel AM; Harris AL; Athanasou NN; Mantovani A; Zallone A; Bussolino F
J Bone Miner Res; 2006 Feb; 21(2):207-18. PubMed ID: 16418776
[TBL] [Abstract][Full Text] [Related]
12. Could local deliver of bisphosphonates be a new therapeutic choice for Gorham-Stout syndrome?
Sun S; Liu X; Ma B; Zhou Y; Sun H
Med Hypotheses; 2011 Feb; 76(2):237-8. PubMed ID: 21044823
[TBL] [Abstract][Full Text] [Related]
13. Chronic recurrent Gorham-Stout syndrome with cutaneous involvement.
Johnstun J; Brady L; Simstein R; Duker N
Rare Tumors; 2010 Sep; 2(3):e40. PubMed ID: 21139956
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic Endothelial Cells Produce M-CSF, Causing Massive Bone Loss in Mice.
Wang W; Wang H; Zhou X; Li X; Sun W; Dellinger M; Boyce BF; Xing L
J Bone Miner Res; 2017 May; 32(5):939-950. PubMed ID: 28052488
[TBL] [Abstract][Full Text] [Related]
15. The importance of computed tomography (CT) scans in the early diagnosis of Gorham-Stout Disease - A case report.
Hyseni F; Vokshi V; Kola E; Fathma S; Guy A; Bushati F; Ahmetgjekaj I; Hla D; Saliaj K; Ikram S; Mohamed EA; Bajwa IA; Nasir F; Musa J
Radiol Case Rep; 2022 Mar; 17(3):492-495. PubMed ID: 34950281
[TBL] [Abstract][Full Text] [Related]
16. Combined neodymium-doped yttrium aluminum garnet laser and sclerotherapy in Gorham-Stout syndrome.
Reipschläger M; Huebner U; Seemann J; Kutzner H; Hoeger PH
JAAD Case Rep; 2018 Jun; 4(5):458-461. PubMed ID: 29984282
[TBL] [Abstract][Full Text] [Related]
17. Gorham-Stout Disease with Clinical Response to Sirolimus Treatment.
Forero Saldarriaga S; Vallejo C; Urrea Pineda L; Osma A; Bonilla Gonzalez C
Eur J Case Rep Intern Med; 2021; 8(8):002740. PubMed ID: 34527618
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid leakage in Gorham-Stout disease due to dura mater involvement after progression of an osteolytic lesion in the thoracic spine.
Suero Molina EJ; Niederstadt T; Ruland V; Kayser G; Stummer W; Ewelt C; Rössler J
J Neurosurg Spine; 2014 Dec; 21(6):956-60. PubMed ID: 25325172
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features and Prognosis of Generalized Lymphatic Anomaly, Kaposiform Lymphangiomatosis, and Gorham-Stout Disease.
Ozeki M; Fujino A; Matsuoka K; Nosaka S; Kuroda T; Fukao T
Pediatr Blood Cancer; 2016 May; 63(5):832-8. PubMed ID: 26806875
[TBL] [Abstract][Full Text] [Related]
20. Gorham-Stout disease with life-threatening pleural effusion treated with a pleuro-peritoneal shunt: a case report.
Toivonen LA; Neva MH; Sioris T; Isomäki P; Metso S
Endocrinol Diabetes Metab Case Rep; 2022 Jun; 2022():. PubMed ID: 35642669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
